Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Merck
Julphar
Federal Trade Commission
Cerilliant
Cantor Fitzgerald
McKinsey
Covington
Accenture

Generated: November 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,245,766

« Back to Dashboard

Which drugs does patent 6,245,766 protect, and when does it expire?

Patent 6,245,766 protects GEODON and is included in two NDAs.

This patent has fifteen patent family members in fourteen countries.

Summary for Patent: 6,245,766
Title: Method of treating psychiatric conditions
Abstract:A method for treating a psychiatic condition or disorder selected from anxiety disorders such as panic disorder, posttraumatic stress disorder and phobias, psychotic episodes of anxiety, anxiety associated with psychosis, psychotic mood disorders such as severe major depressive disorder and mood disorders associated with psychotic disorders such as acute mania or depression associated with bipolar disorder, schizophrenia, behavioral manifestations of mental retardation, conduct disorder or autistic disorder, dementias such as dementias of the Alzheimer's type, and dyskinesias such as drug induced and neurodegeneration based dyskinesias in a mammal, including a human, comprising administering to said mammal a pharmaceutically effective amount of a compound of the formula ##STR1## or a pharmaceutically acceptable acid addition salt thereof, wherein n, X, Y and Ar are as defined above.
Inventor(s): Watsky; Eric J. (Stonington, CT)
Assignee: Pfizer Inc (New York, NY)
Application Number:09/216,334
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 6,245,766

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Pfizer GEODON ziprasidone hydrochloride CAPSULE;ORAL 020825-001 Feb 5, 2001 AB RX Yes Yes ➤ Sign Up ➤ Sign Up TREATMENT OF BIPOLAR DISORDER ➤ Sign Up
Pfizer GEODON ziprasidone hydrochloride CAPSULE;ORAL 020825-002 Feb 5, 2001 AB RX Yes No ➤ Sign Up ➤ Sign Up TREATMENT OF BIPOLAR DISORDER ➤ Sign Up
Pfizer GEODON ziprasidone hydrochloride CAPSULE;ORAL 020825-003 Feb 5, 2001 AB RX Yes No ➤ Sign Up ➤ Sign Up TREATMENT OF BIPOLAR DISORDER ➤ Sign Up
Pfizer GEODON ziprasidone hydrochloride CAPSULE;ORAL 020825-004 Feb 5, 2001 AB RX Yes No ➤ Sign Up ➤ Sign Up TREATMENT OF BIPOLAR DISORDER ➤ Sign Up
Pfizer Inc GEODON ziprasidone hydrochloride SUSPENSION;ORAL 021483-001 Mar 29, 2006 DISCN No No ➤ Sign Up ➤ Sign Up TREATMENT OF BIPOLAR DISORDER ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 6,245,766

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 231394 ➤ Sign Up
Australia 739472 ➤ Sign Up
Australia 9717098 ➤ Sign Up
Canada 2256227 ➤ Sign Up
Germany 69810889 ➤ Sign Up
Denmark 0931547 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Fish and Richardson
Federal Trade Commission
McKesson
Fuji
Moodys
Johnson and Johnson
UBS
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.